Medical network on April 14-8th of this month, Beijing medical separate comprehensive reform policy, the full implementation of the drug sun synchronous implementation of the procurement as one of the measures. Yesterday, the Beijing morning paper reporter learns from the city planning commission, as of April 11, sun officially run 4 days of drug price concession contracts totaling 59.64 million yuan. City health development planning commission, said the results fully meet reform expectations. 

 

Save drug purchase cost nearly 3 billion 

 

All this time, the city's public medical institutions in the use of all drugs (poison ganga, national immunization programmes vaccine, Chinese medicine yinpian except is beyond the scope of the procurement of medicines) include all sunlight procurement scope. Drug sunlight procurement in accordance with the principle of the unity of quality and demand, price, a "sort drug procurement, insist on quality first, price have rise and fall", namely through combining with the actual market supply and demand situation, the scientific design rules of drug purchase, to ensure drug quality and ensure drug supply. 

 

After the reform, drug overall cost decreased obviously. According to the public medical institutions in the city 2015 annual drug purchase quantity calculation, the city's public medical institutions can cut down the cost of drug purchase of about 2.88 billion yuan a year. 

 

Only 5% of the price of drug purchase amount 

 

The reporter understands, the sunlight procurement specific approach is to divide drugs into three categories: the first kind is the market well supplied, competition fully commonly used drugs, dynamic linkage with the provincial drug centralized purchasing price all over the country, and as a basis for important negotiations, further reducing drug prices artificially high, guide the national low level of the same drug prices in the city. 

 

The second category of drugs is mainly to ensure that clinical medicine supply in the first place, improve drug prices reasonable, especially improving the shortage of national, regional and drug price, can in the case of shortages effectively occupy market opportunities, but also can promote the enterprises to actively production. Such as the shortage of prophase protamine, actinomycin D, a sulfhydryl imidazole, atropine sulfate to basic relief. 

 

The third type of low-cost drugs according to the relevant national policies, encourage enterprises to more production and clinical use more drugs at a lower price, in order to achieve the purpose of reducing the gross cost of medical. Price without violating national drug policy basis, avoid delisting risk cheap drugs, medical institutions refer to the surrounding provinces and cities actual supply price, subject to form supply price negotiations with production enterprises. 

 

Special interest for high quality brands proprietary Chinese medicine, because the raw material price rising year by year, this class of drugs in recent years the price increases are common. To ensure the quality of drugs, drug prices not only low price theory, such drug prices rose after the reform, but the price level in the national or regional low. According to statistics, prices of pharmaceuticals procurement amount accounts for only 5% of the total amount of the drug. 

 

To investigate "no reason to increase the price" 

 

It is understood that the combination of the city health development planning commission and city food food and drug administration has medical institutions and drug distribution enterprises request, for prices due to shortage of medicines, medical institutions should be replaced timely argument substitution, varieties, and drug distribution enterprises to actively communication and consultation, reference to determine the level of other provinces and cities in the same period the price clinch a deal the price reasonable, ensure drug supply. 

 

At the same time, the two departments will also develop price supervision department of the joint development and reform commission, the price rise in price product, with no reason to increase the price behavior, determined to investigate. 

 

S authority to respond to 

 

Why part of the price the same? 

 

Patients question: after the reform, all say medical costs will come down, why to community part prescription drug prices and price is the same as before? 

 

Who planning commission a: grassroots medical institutions in the city as early as in 2006, began to implement the zero rate of basic drugs sales. Before these drugs in the medicine separately perform comprehensive reform, the community has cancelled the drug addition. In 2014, the city will be expanded to 699 kinds of essential drugs variety, and carried out the national provincial drug centralized purchasing price linkage, many products are already in the low price, so the price has no obvious change after the reform of execution. 

 

The purchase of the sun, according to the principle of classification of procurement, drug prices have rise and fall, and part of the price. Such as worship the sugar level (acarbose tablets) as early as in 2009 has been in the community to achieve a zero rate of sales, 2014 basic has complete linkage in drug price linkage, so the purchasing price has no obvious change before and after the execution in the sunshine, stable to maintain a relatively low price level in the country. 

 

Why some prices rise? 

 

Question: in patients with long-term use of available kyushin pills, rose more than 9 yuan, after the reform what was the reason for the rise in price? 

 

Who planning commission answer: according to the traditional average daily cost no more than 5 yuan can be incorporated into the low price of drug policy management principle, readily kyushin pills are owned by the state, low price range of drug policy. National policy is to increase policy support for these drugs, encourage the production and clinical use more cheap drugs. Price without violating the national policy on the basis of cheap drugs, medical institutions may refer to provinces surrounding the price, subject to form supply price negotiations with production enterprises. 

 

At the same time, the main raw material of proprietary Chinese medicine herbs, belongs to the agricultural and sideline products, the price with the agricultural market price fluctuations is bigger, and prices rise continuously in recent years. Via checking, quick-acting kyushin pills, though prices have gone up as the surrounding provinces, but the average daily cost is low, still belongs to the scope of cheap drugs. Calculated according to different packaging the product quantity, the price of 39.72 yuan converted into single grain is about 0.22 yuan, has for the lower level.